Click Here to return To Results

 

Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches Neurol 77:1827-1832, Nagy, A.J.,et al, 2011 See this aricle in Pubmed Article Abstract Intravenous dihydroergotamine is well-tolerated, and longer treatments produce a better outcome. Nausea is the most common adverse effect, and its control associated with a better outcome.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction cluster headache efficacy ergotamine headache headache,intractable headache,treatment of hospitalization intravenous migraine migraine,chronic nausea and vomiting safety treatment of neurologic disorder

Click Here to return To Results